Expertise in
8
conditions

Marcia T. Delamain

Belo Horizonte, MG, BR 
Expertise in
8
conditions
Belo Horizonte, MG, BR 

Overview

Marcia Delamain practices practicing medicine in Belo Horizonte, Brazil.

Ms. Delamain is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Diffuse Large B-Cell Lymphoma (DLBCL), Hodgkin Lymphoma, and Non-Hodgkin Lymphoma.

She is actively involved in clinical research, co-authoring 44 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Belo Horizonte, MG, Brazil
Other Locations
Campinas, RS, Brazil
Campinas, SP, Brazil
Sao Paulo, SP, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Indolent Non Follicular Lymphomas Prognostic Project - Prospective Collection of Data of Possible Prognostic Relevance in Patients With Indolent Non-follicular B-CELL Lymphomas
Indolent Non Follicular Lymphomas Prognostic Project - Prospective Collection of Data of Possible Prognostic Relevance in Patients With Indolent Non-follicular B-CELL Lymphomas
Enrollment Status: Completed
Publish Date: August 08, 2025
Intervention Type: Other
Pilot Study of Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia With Deep Molecular Response - Evaluation of Pioglitazone in Treatment-free Remission (EDI-PIO)
Pilot Study of Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia With Deep Molecular Response - Evaluation of Pioglitazone in Treatment-free Remission (EDI-PIO)
Enrollment Status: Completed
Publish Date: March 30, 2025
Intervention Type: Other, Drug
Study Drug: Pioglitazone
Study Phase: Phase 2
View 1 Less Clinical Trial

44 Total Publications

Therapeutic Plasma Exchange: Analysis of Practices and Compliance With International Guidelines.
Therapeutic Plasma Exchange: Analysis of Practices and Compliance With International Guidelines.
Journal: Journal of clinical apheresis
Published: October 10, 2024

Frequently Asked Questions about Marcia T. Delamain

Is Marcia T. Delamain a top-rated expert for Chronic Myelogenous Leukemia (CML)?

MediFind is an objective health platform that identifies experts based on real-world data. Marcia T. Delamain is classified as an Advanced expert for Chronic Myelogenous Leukemia (CML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marcia T. Delamain participate in research or clinical trials?

Yes. Marcia T. Delamain has published 44 articles and abstracts on conditions like Chronic Myelogenous Leukemia (CML). You can view a list of Marcia T. Delamain's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Delamain's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile